Autus Asset Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15,072
Closed -$3.7M 148
2022
Q3
$3.7M Sell
15,072
-44
-0.3% -$11.9K 0.71% 57
2022
Q2
$3.74M Buy
15,116
+210
+1% +$56.7K 0.67% 56
2022
Q1
$4.94M Sell
14,906
-5,653
-27% -$1.74M 0.74% 50
2021
Q4
$7.38M Sell
20,559
-161
-0.8% -$54.4K 0.74% 54
2021
Q3
$6.75M Buy
20,720
+77
+0.4% +$26.1K 0.74% 54
2021
Q2
$6.44M Sell
20,643
-133
-0.6% -$40.8K 0.71% 58
2021
Q1
$6.62M Buy
20,776
+522
+3% +$167K 0.78% 53
2020
Q4
$6.57M Sell
20,254
-1,583
-7% -$438K 0.85% 50
2020
Q3
$6.05M Sell
21,837
-449
-2% -$129K 0.8% 49
2020
Q2
$5.38M Buy
22,286
+1,965
+10% +$395K 0.78% 53
2020
Q1
$2.95M Buy
+20,321
New +$3.37M 0.52% 60

Other funds holding ABMD

Autus Asset Management's ABMD Position: Q4 2022 in Review

Autus Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 15,072 shares — an estimated $3.7M sold.

Autus Asset Management first reported a position in ABMD in Q1 2020 and held it in 11 quarters. The position peaked at $7.38M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Autus Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Autus Asset Management sold 15,072 Abiomed Inc shares in Q4 2022, an estimated $3.7M.
  • Autus Asset Management first reported a position in Abiomed Inc in Q1 2020 and held it in 11 quarters.
  • Autus Asset Management's Abiomed Inc position peaked at $7.38M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Autus Asset Management's 13F filing for Q4 2022, filed 24 Jan 2023.